47 results on '"Fibrosis -- Models"'
Search Results
2. Aberrant Transitional Alveolar Epithelial Cells Promote Pathogenic Activation of Lung Fibroblasts in Preclinical Fibrosis Modeling
3. NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone
4. New Liver Fibrosis Study Findings Have Been Reported by Investigators at Sun Yat-sen University (Us-based Sequential Algorithm Integrating an Ai Model for Advanced Liver Fibrosis Screening)
5. The TNF{blacktriangleup}ARE mouse as a model of intestinal fibrosis
6. Omega Therapeutics Showcases Bidirectional & Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
7. CD8 T cell hyperfunction and reduced tumour control in models of advanced liver fibrosis
8. Human liver microbiota modeling strategy at the early onset of fibrosis
9. Findings on Cell Surface Receptors Reported by Researchers at SBP Medical Discovery Institute (Extra-cellular matrix induced by steroids and aging through a G-protein coupled receptor in a Drosophila model of renal fibrosis)
10. Researchers from Kanazawa Medical University Detail Findings in Diabetes Research (CD-1db/db mice: a novel type 2 diabetic mouse model with progressive kidney fibrosis)
11. Findings on Liver Fibrosis Reported by Researchers at Catholic University of Korea (A novel antifibrotic strategy utilizing conditioned media obtained from miR-150-transfected adipose-derived stem cells: validation of an animal model of liver ...)
12. Studies from University Health Network Yield New Information about Heart Failure (Human Cardiac Fibrosis-on-a-chip Model Recapitulates Disease Hallmarks and Can Serve As a Platform for Drug Testing)
13. Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis Model
14. Targeting Acid Ceramidase Ameliorates Fibrosis in Mouse Models of Nonalcoholic Steatohepatitis
15. MAX BioPharma Announces Publication of Proof of Principle Regarding its Oxysterol Lead Drug Candidate, Oxy210 that Inhibits Fatty Liver and Fibrosis in a Humanized Mouse Model
16. New Hepatology Study Findings Have Been Reported by Investigators at Icahn School of Medicine at Mount Sinai (Single-cell Transcriptomics Reveals Conserved Cell Identities and Fibrogenic Phenotypes In Zebrafish and Human Liver)
17. Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system
18. New Findings from University of Manitoba in the Area of Liver Fibrosis Reported (Active immunization against transforming growth factor beta1 prevents hepatic fibrosis in a rat model of liver disease)
19. Estimating the Inter- and Intra-Rater Reliability for NASH Fibrosis Staging in the Presence of Bridge Ordinal Ratings with Hierarchical Bridge Category Models (Updated October 30, 2021)
20. New Findings in Extracellular Matrix Proteins Described from Xiangya Hospital (Proteomic Analysis Exploring the Mechanism of Bladder Fibrosis Induced By Ketamine Using a Rat Model)
21. Research on Clinical Medicine Published by Researchers at Institute of Biomedical Engineering (Non-Invasive and Quantitative Estimation of Left Atrial Fibrosis Based on P Waves of the 12-Lead ECG-A Large-Scale Computational Study Covering ...)
22. Studies by G. Castoldi and Co-Authors Describe New Findings in Hypertension (Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis)
23. Targeting fibrosis in the Duchenne Muscular Dystrophy mice model: an uphill battle
24. Researchers at Hagey Laboratory for Pediatric Regenerative Medicine Release New Data on Disease Models and Mechanisms (Understanding the impact of fibroblast heterogeneity on skin fibrosis)
25. D9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in murine models of chemically- and obesity-induced liver injury
26. Studies from Central South University Provide New Data on Transforming Growth Factors (Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery)
27. Reports Outline Hepatic Fibrosis Study Findings from Takeda Pharmaceutical Company (Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis)
28. ChemoCentryx's CCR2 Inhibitor CCX872 Shown to Reduce Liver Fibrosis in NASH Models
29. ChemoCentryx's CCR2 Inhibitor CCX872 Shown to Reduce Liver Fibrosis in NASH Models
30. ChemoCentryx's CCR2 Inhibitor CCX872 Shown to Reduce Liver Fibrosis in NASH Models
31. Researchers' Work from Department of Infectious Diseases Focuses on Chronic Hepatitis B Virus (A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B)
32. Studies from H.M. Lin and Co-Researchers Yield New Data on Hepatic Fibrosis (Model-dependent and model-independent approaches for evaluating hepatic fibrosis in rat liver using shearwave dispersion ultrasound vibrometry)
33. Data on Thrombosis Reported by Researchers at Xi'an Jiaotong University (Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model)
34. Galectin Therapeutics Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 is Efficacious in Preclinical Model of Fatty Liver Disease With Fibrosis
35. Researchers at Tulane National Primate Research Center Have Reported New Data on Clostridium [Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis]
36. Data on Intercellular Signaling Peptides and Proteins Reported by Researchers at University Hospital (Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis)
37. Data from Department of Pathology Provide New Insights into Hepatic Fibrosis (Quantitative Imaging: Quantification of Liver Shape on CT Using the Statistical Shape Model to Evaluate Hepatic Fibrosis)
38. Antegrin Announces Publication in Nature Medicine of Preclinical Data in Fibrosis Models
39. Promedior Announces Presentation of Data at ARVO Demonstrating that Pentraxin-2 Suppresses Fibrosis, Neovascularization, and Vascular Leak in Retinal Disease Models
40. Antegrin Announces Publication in Nature Medicine of Preclinical Data in Fibrosis Models
41. Research from University of Paris in the area of fibrosis described
42. A noninvasive model predicts significant fibrosis in HBeAg-positive patients
43. A noninvasive model predicts significant fibrosis in HBeAg-positive patients
44. A noninvasive model predicts significant fibrosis in HBeAg-positive patients
45. Liver fibrosis predictive model validated in HIV/HCV-coinfected patients
46. Liver fibrosis predictive model validated in HIV/HCV-coinfected patients
47. Liver fibrosis predictive model validated in HIV/HCV-coinfected patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.